Weider focuses on eye health
This article was originally published in The Tan Sheet
Schiff Lutein will be "specially formulated with a higher level of zeaxanthin" than competing supplements because ingredient "is more concentrated in the middle of the fovea, where light impacts the retina," Salt Lake City-based Weider announces May 23. Eye health supplement contains 5 mg lutein, 1 mg zeaxanthin, as well as vitamins A, C, E, zinc and copper, and "helps promote healthy eyes by maintaining macular and retinal health," Weider says. Schiff Lutein will launch at food, drug and health stores nationwide in late spring; a 30-day supply will sell for $9.99-$15.99...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.